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Isolated Case of Mental Retardation and Ataxia Due 
to a De Nlovo Mitochondrial T8993G Mutation
To the Editor:
Neurogenic muscle weakness, ataxia, and retinitis pig­
mentosa (NARP) and subacute necrotizing encephalo- 
myelopathy (Leigh disease) are both associated with an 
alteration of nt 8993 in the mitochondrial ATPase 6 
gene. In NARP, the T-to~G transversion at that position 
changes leucine into arginine (Holt et al. 1990). In Leigh 
syndrome, the same mutation can be found (Tatuch et 
al. 1992), as can a T-to-C transition (de Vries et al. 
1993), which changes this leucine into proline. Clinical 
manifestations occur for NARP when ^60% -90%  mu­
tated mtDNA is present. In case of Leigh, these percent­
ages usually exceed 95% (Tatuch et al. 1994). It is 
known that this mutation can segregate very rapidly 
within pedigrees (Santorelli et aL 1993; Tulinius et al. 
1995). Here we report on a sporadic case with mental 
retardation and ataxia without retinitis pigmentosa in 
which the T8993G mutation was found.
The patient was born, after an uncomplicated preg­
nancy, with a perinatal asphyxia. The neonatal period 
was unremarkable. Because of complaints about exer­
cise intolerance and slow recovery after viral infections, 
she was medically investigated at the age of 5 years. 
Clinical examination determined her to be moderately 
mentally retarded. She showed a cerebellar ataxia with 
a normal muscle tone and extensor plantar responses. 
No signs of hearing or vision impairment were noted, 
and retinitis pigmentosa was excluded by careful oph- 
thalmological investigations. Tests for cardiac func­
tions, magnetic resonance imaging, electroencephalo­
graphy, electromyography, and nerve-conduction stud­
ies showed no abnormalities. Biochemical investigation 
revealed an elevated lactic acid level in blood and cere­
brospinal fluid. A muscle biopsy revealed no morpholog­
ical or histochemical abnormalities. The clinical findings 
are consonant with the spectrum of symptoms in Leigh 
disease (Tatuch et al. 1992). None of the members of 
the family shown in figure 1 showed evidence of a neuro­
logical disorder, on clinical examination.
DNA isolated from the muscle sample of the patient 
was analyzed for mutations in the mtDNA. Deletions 
and the point mutations at nucleotide positions 3243, 
3271, 8344, and 8356 were excluded. In order to detect 
the NARP/Leigh mutations, a 633-bp DNA fragment 
containing nt 8993 was amplified and digested with 
Hpall for the T-to-G or the T-to-C mutation and with 
Aval for the T-to-G mutation (de Vries et al. 1993). The 
PCR fragment could be digested with Aval and Hpall 
(data not shown), indicating the T8993G transversion. 
A radioactive PCR was performed, and the signal inten­
sities of the bands after Aval digestion were compared, 
to determine the amount of mutated mtDNA. Radioac­
tive [a-32P]dCTP was added before the last elongation 
of the PCR reaction, to ensure that the intensity ratio 
of the Aval fragments was a true reflection of the in vivo 
heteroplasmy. The patient’s DNA from peripheral blood 
cells and muscle showed 74% and 79% mutated DNA, 
respectively. The same test was performed on DNA sam­
ples of the mother, sister, and maternal relatives of the 
patient. For the mother, peripheral white blood cells, 
fibroblasts, and a muscle sample were tested. However, 
even after prolonged autoradiographic exposure, no mu­
tated mtDNA could be observed in any of the maternal 
tissues (data not shown). The sensitivity of the radioac­
tive PCR test, estimated by dilution of the patient sample 
with a normal sample, was estimated to be >0.1% . 
Supportive evidence for the absence of the mutation in 
the mother can be derived from her healthy sibs and 
daughter, who were also negative for the T8993G muta­
tion. To our knowledge, it has never been reported that 
the muscle tissue was negative in patients in whom a 
mtDNA mutation was found. The occurrence of a de 
novo mutation is the most likely explanation for our 
observations.
The spontaneous occurrence of mutated mtDNA in 
this patient is similar as the occurrence of deleted 
mtDNA seen in most patients with Pearson syndrome 
who also have a negative family history. Santorelli et al.
(1993) and Tulinius et ah (1995) have also reported
evidence for new mutations, but in these cases the 
asymptomatic mothers were carrier of appreciable 
amounts of mutated mtDNA. In cows, it has been ob­
served that the mitochondrial genome can be replaced 
completely by a nucleotide-sequence variant within a 
single generation (Koehler et al. 1991). Very recently, it 
has been shown that low levels of deleted mtDNA do 
occur in oocytes, which are comparable to levels seen 
in tissue specimens of older subjects (Chen et al. 1995).
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Figure 1 Pedigree of die T8893G-positive patient with mental retardation and ataxia. The percentages given below the pedigree symbols 
are die percentages mutated mtDNA found in blood (bl), fibroblasts (fi)} and muscle (mu).
Since point mutations do arise on aging, it is not unlikely 
that point mutations occur in oocyte mtDNA also. At- 
tardi and coworkers have put forward the hypothesis 
that the mitochondrion is the unit of segregation 
(Yoneda et al. 1992). It might very well be that in our 
case the mutation has arisen before or during the mito­
chondrial expansion in the oocyte. In the stochastic puri­
fication following the dilution of the mtDNA down to 
one copy per organelle (Ashley et al. 1989), one mito­
chondrion with only mutated mtDNA may have sur­
vived. In the developing organism, the mutated mtDNA 
may have expanded because of the feedback mechanism 
of the functionally compromised mitochondria. One 
may wonder, then, whether this should be a rare event. 
Recent in vitro experiments with various mtDNA point 
mutations in mtDNA-less cells indicate that, in culture, 
the shift to either wild type or mutant may be dependent 
on the nuclear background (Yoneda et al. '1992; Cho- 
myn et al. 1994; Mariotti et al. 1994; Dunbar et al. 
1995). Obviously, identification of such nuclear-en- 
coded, possibly tissue-specific, modifier genes will be 
needed to understand the genesis and frequency of 
mtDNA disorders.
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High Frequency of Mutations in Codon 98 of the 
Peripheral Myelin Protein Po Gene in 20 French 
CMT1 Patients
To the Editor:
(=^40 m/s) associated with hypertrophic onion bulb 
changes on nerve biopsy (Dyck et al. 1993).
Autosomal dominant CMT1 is genetically heteroge­
nous: CMT1A is caused by a 1.5-Mb duplication in 
1 7 p ll.2  (Lupski et al. 1991b; Brice et al. 1992; Raey- 
maekers et al. 1992) and, more rarely, by a point muta­
tion in the PMP22 (peripheral myelin protein, 22 kD) 
gene located in the duplicated region (Valentijn et al. 
1992; Roa et al. 1993); CMT1B results from mutations 
in the Po (peripheral myelin protein zero) gene in lq22- 
23. Forty-five percent (7/16) of the published mutations 
associated with CMT1 occur in exon 3 of Po (Hayasalca
et al. 1993a} 1993b9 1993c; Himoro et al. '1993; Kulkens 
et al. '1993; Roa et al. 1993; Nelis et al. 1994; Latour 
et al. 1995).
In order to determine the cause of CMT1 in 20 unre­
lated patients without 17p ll.2  duplications, mutations 
were sought in exon 3 of Po with three techniques: non­
radioactive SSCP, automated sequencing, and PCR en­
zymatic restriction.
All index patients fulfilled the diagnostic criteria for 
CMT1, but family histories were absent in 10 cases. 
Median motor nerve conduction velocities (MMNCV) 
were =^38 m/s (19.6 ± 6.8 m/s). Duplication in 17p ll.2  
was excluded with RFLP probes VAW409R3a 
(D17S122), EW401 (D17S61), or VAW412 (D17S125) 
(Raeymaekers et al. 1992).
The exon 3 of Po was amplified using intronic primers
1 (5'~GGGTCCTCTCACATGCTTCC-3') and 2 (5'- 
AACTGCTTCCCATACCCTTG-3') (Pham-Dinh et al. 
1993), which generate a 288-bp fragment. The PCR 
products were (1) analyzed by nonradioactive SSCP as 
described elsewhere (Orita et al. 1989; authors’ unpub­
lished data), and (2) directly sequenced using the Taq 
polymerase (Prism Taq DyeDeoxy Terminator Cycle Se­
quencing Kit, Perkin Elmer) and analyzed on an Applied 
Bio-Instruments automatic sequencer. The 5'-*3' and 
3'-*5' strands were both analyzed using the primers 1 
and 2, respectively. (3) The PCR products were then 
digested by Cfol restriction enzyme (1.0 U/reaction) and 
analyzed on a 1% agarose gel.
Twenty unrelated CMT1 patients were first analyzed 
by nonisotopic SSCP for exon 3 of Po gene. An abnormal 
but different migration profile was detected for individu­
als SAL-297-5 and SAL-1187-3 (figs. 1 and 2). In both 
cases, a different new mutation involving codon 98 was 
found. In individual SAL-297-5, a missense Arg98Pro
Charcot-Marie-Tooth disease, characterized by distal mutation was caused by a G->C transversion at nt 293,
muscle weakness and amyotrophy, decreased or absent whereas a C->T transition at nt 292 was responsible
tendon reflexes, and high arched feet (Dyck et al. 1993), for an Arg98Cys substitution in individual SAL-1187-
is the most common inherited peripheral neuropathy, 3. Since these mutations abolished a Cfol restriction site,
with a prevalence of 1 in 2,500 (Skre 1974). Two types which cleaves the 288-bp PCR fragment in two parts of
of CMT have been distinguished on the basis of nerve '194 bp and 94 bp, it was possible to test relatives in
conduction velocities (Lupski et al. 1991a), CMT type both families for the presence of the restriction site. In
1 is the most frequent, with markedly slowed velocities family SAL-297, the restriction site was present in five
